Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000588
Filing Date
2024-09-16
Accepted
2024-09-16 17:01:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 rvnc13g.htm SC 13G 66553
  Complete submission text file 0000935836-24-000588.txt   68154
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 241301791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277
Business Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277 9174461561
Beryl Capital Management LLC (Filed by) CIK: 0001719307 (see all company filings)

EIN.: 474641111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G